International Perfusion Association

Social:

Facebook Instagram Linkedin
IPA

Logo

Heart to Heart Mission

For more than 20 years, the IPA has performed life-saving heart surgery on over 400 patients in Santiago, Dominican Republic.

Read More
Logo

Honduras Mission

The IPA is working with Duke to expand their heart surgery mission program in Honduras. We have a mission trip planned for mid-May. Stay tuned for more information.

Read More
Logo

Your Mission Trip

The IPA will gladly make donations to qualified charitable organizations who perform cardiac surgery mission work for patients in need.

Read More

600+

Patients served

Help Mend a Heart!

Every member of our team is an unpaid volunteer, so please take comfort in knowing that 100% of all donated funds go directly to patient care. Your generosity is so very welcome and will help save lives!
Make a Donation

— Latest News —

Infection 1

Nosocomial Infections After Pediatric Congenital Heart Disease Surgery: Data from National Center for Cardiovascular Diseases in China

This study evaluates nosocomial infections in pediatric patients post-cardiac surgery, analyzing data from the National Center for Cardiovascular Diseases in China. Out of 4776 patients, the nosocomial infection rate was 2.1%, with multidrug-resistant organisms (MDROs) found in 36 patients. Pneumonia and sepsis were the most common infections, with pneumonia showing an incidence density of 7.2/1000 patient-days. MDRO infections were associated with significantly longer intensive care unit stays compared to non-MDRO infections. The results highlight the impact of MDRO infections on surgical outcomes and the importance of infection prevention and control measures.

READ MORE
May 4, 2024
Myocardial Protection

Dexmedetomidine Pretreatment Confers Myocardial Protection and Reduces Mechanical Ventilation Duration for Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass

This study investigates the effects of dexmedetomidine (Dex) pretreatment in patients undergoing cardiac valve replacement under cardiopulmonary bypass. In the Dex group, the time to the first rescue dose of propofol was longer, and the total propofol dosage was less than in the control group. Additionally, the Dex group showed reduced cardiac injury markers and inflammation, requiring less mechanical ventilation time than the control group. The findings suggest that Dex pretreatment offers myocardial protection and optimizes postoperative outcomes.

READ MORE
May 2, 2024
TAVR 2024

Long-Term Impact of Cardiac Damage Following Transcatheter Aortic Valve Replacement

This study explores the prognostic implications of changes in cardiac damage following transcatheter aortic valve replacement (TAVR). Analyzing 1,863 patients from the SwissTAVI Registry, researchers found significant variations in cardiac damage stages pre- and post-TAVR, affecting long-term survival. Nearly half of the patients experienced changes in cardiac stage, highlighting the importance of cardiac damage evaluation for predicting outcomes after TAVR.

READ MORE
April 30, 2024
Searchable News